GlassScriptPhysician profile
Lance Richard Winter
NPI 1386693976
$4,965.37
in general payments reported to CMS, 2019-2025
30 companies · $434 in 2025
The $434 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,140 · 2020: $173 · 2021: $740 · 2022: $685 · 2023: $259 · 2024: $534 · 2025: $434.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,227.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,355.86 | 2019-2024 | Inhance |
| Depuy Synthes Sales INC. | $1,308.05 | 2019-2024 | Monovisc, Attune |
| Carbofix Orthopedics INC | $1,232.79 | 2021-2025 | |
| Djo, LLC | $193.54 | 2019-2023 | Cmf |
| Sanara Medtech INC. | $170.00 | 2025 | Celleraterx |
| Abbott Laboratories | $108.00 | 2021 | |
| Bioventus LLC | $55.07 | 2022-2024 | Exogen Ultrasound Bone Healing System, Gelsyn-3 |
| Chiesi USA, INC. | $48.54 | 2021-2022 | |
| Medartis INC. | $47.77 | 2020 | |
| Smith+Nephew, INC. | $44.07 | 2023-2024 | Pico 7, Pico, Renasys Go V2 Home |
| Orthofix Medical, INC. | $35.69 | 2019-2021 | |
| Abbvie INC. | $33.64 | 2021 | |
| Janssen Pharmaceuticals, INC | $32.19 | 2019-2020 | |
| Horizon Therapeutics Plc | $26.72 | 2019 | |
| Molnlycke Health Care US, LLC | $23.67 | 2024 | Avance, Mepilex Border Post-Op Ag |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $23.15 | 2019 | |
| Osiris Therapeutics INC. | $21.12 | 2019 | |
| Medtronic USA, INC. | $20.73 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.65 | 2025 | Lifevest |
| Mallinckrodt Enterprises LLC | $19.34 | 2019 | |
| Boston Scientific Corporation | $17.71 | 2021 | |
| Biotissue Holdings INC. | $17.15 | 2022 | |
| Vericel Corporation | $16.93 | 2024 | Maci |
| Anika Therapeutics, INC. | $16.33 | 2025 | Integrity Implant |
| Shire North American Group INC | $16.26 | 2019 | |
| Theragen, INC. | $14.92 | 2022 | |
| Trice Medical, INC. | $14.75 | 2022 | |
| Avanos Medical | $14.30 | 2023 | Genvisc 850 Sodium Hyaluronate |
| Bayer Healthcare Pharmaceuticals INC. | $13.55 | 2021 | |
| Illuminoss Medical, INC. | $3.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lance Winter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.